与比卡鲁胺相比，恩杂鲁胺真的能降低去势抵抗性前列腺癌患者的疾病进展风险吗？ - Suppr

Does Enzalutamide Really Reduce the Risk of Progression Compared With Bicalutamide in Patients With Castration-Resistant Prostate Cancer?

Şendur Mehmet Ali Nahit, Yalçın Bülent

Mehmet Ali Nahit Şendur and Bülent Yalçın, Yildirim Beyazit University, Ankara, Turkey.

J Clin Oncol. 2017 Jan;35(1):122. doi: 10.1200/JCO.2016.68.0389. Epub 2016 Oct 31.

Abstract

摘要

J Clin Oncol. 2017 Jan;35(1):122. doi: 10.1200/JCO.2016.68.0389. Epub 2016 Oct 31.

Eur Urol. 2017 Apr;71(4):534-542. doi: 10.1016/j.eururo.2016.07.027. Epub 2016 Aug 3.

J Urol. 2018 Jan;199(1):147-154. doi: 10.1016/j.juro.2017.08.080. Epub 2017 Aug 19.

J Clin Oncol. 2016 Jun 20;34(18):2098-106. doi: 10.1200/JCO.2015.64.9285. Epub 2016 Jan 25.

J Urol. 2016 Sep;196(3):741-4. doi: 10.1016/j.juro.2016.06.066. Epub 2016 Jun 16.

J Clin Oncol. 2017 Jan;35(1):123. doi: 10.1200/JCO.2016.67.4630. Epub 2016 Oct 31.

Lancet Oncol. 2016 Feb;17(2):153-163. doi: 10.1016/S1470-2045(15)00518-5. Epub 2016 Jan 14.

BMC Res Notes. 2018 May 29;11(1):342. doi: 10.1186/s13104-018-3453-z.

Nat Rev Urol. 2016 Mar;13(3):124. doi: 10.1038/nrurol.2016.24. Epub 2016 Feb 2.

Clin Cancer Res. 2015 Sep 15;21(18):4133-42. doi: 10.1158/1078-0432.CCR-15-0269. Epub 2015 May 20.

20分钟写一篇综述，助力文献阅读效率提升50倍。

大模型驱动的PubMed中文搜索引擎

学术文献翻译模型，支持多种主流文档格式。